Biomarkers in Lung Cancer-Reference-Cited by-同舟云学术

Biomarkers in Lung Cancer

Published:2020-03 Issue:1 Volume:41 Page:115-127
ISSN:0272-5231
Container-title:Clinics in Chest Medicine
language:en
Short-container-title:Clinics in Chest Medicine

Author:

Sears Catherine R.,Mazzone Peter J.

Funder

Veracyte

OncoCyte

Exact Sciences, SEER, PCORI

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine

Reference92 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

3. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

4. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

5. Screening for lung cancer: CHEST guideline and expert panel report;Mazzone;Chest,2018

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COUNTERPOINT: Liquid Markers for Risk Stratification of Pulmonary Nodules, Ready for Prime Time? Not Yet!;CHEST Pulmonary;2024-09

2. Rebuttal From Dr Nadig et al;CHEST Pulmonary;2024-09

3. FAM65A promotes the progression and growth of lung squamous cell carcinoma in vivo and vitro;BMC Cancer;2024-08-02

4. Lung Cancer: New Directions in Senior Patients Assessment;Geriatrics;2024-08-01

5. Practical issues related to immunocytochemistry on cytological smears: Tips and recommendations;Cytopathology;2024-07-16